24 May 2013
Keywords: united, thera, drops, ovarex, after, fails, usa-based
Article | 10 December 2007
USA-based United Therapeutics Corp plans to discontinue the development of OvaRex, its monoclonal antibody for advanced ovarian cancer, after
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
© 2013 thepharmaletter.com